EMERYVILLE, Calif.,
Feb. 10, 2021 /PRNewswire/
-- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic
biotechnology company active in the Clean Health and Beauty markets
through its consumer brands, and a top supplier of sustainable and
natural ingredients, successfully hosted the second webinar in its
virtual investor mini-series themed "Delivering on the Promise
of Synthetic Biology."
This second webinar entitled "The Science Delivering Clean
and Sustainable Consumer Products" was conducted via live
webcast and teleconference yesterday, Tuesday, February 9, 2021 at 1:00 pm ET (10:00 am
PT).
The webinar was well-attended by more than 600 people. Speaking
on behalf of Amyris during the event were John Melo, President and Chief Executive
Officer; Han Kieftenbeld, Chief
Financial Officer, and a panel consisting of Daya Fields, President, Pipette and Purecane,
Catherine Gore, President,
Biossance, Caroline Hadfield, Chief
Executive Officer, Rose Inc., and
President Aprinnova, and Sheila Shekar
Pollak, Chief Marketing Officer, Biossance. Also on the
panel was guest Julian Reis, Founder
and Chief Executive Officer of SuperOrdinary.
Mr. Melo provided an update on strategic transactions in the
pipeline, the company's proprietary Lab-to-Market capability
creating unique ingredients for consumer products, an overview of
the beauty and personal care market with a focus on the clean
beauty "movement," and a review of the company's clean beauty
consumer brands. The presentation was followed by the panelists
highlighting the unique positioning of Amyris's brands, expected
2021 brand launches, product line extensions, channel expansion,
and geographical expansion with a particular spotlight on the
China market. The session
concluded with an interactive Q&A session.
Presentation materials and a replay of the second virtual
investor mini-series are available in the investor relations
section of Amyris's website at http://investors.amyris.com.
Amyris plans to hold its third session of the investor
mini-series that focuses on its Ingredients portfolio during the
second quarter of 2021. Advance notice of the dates and times of
the session will be provided.
About Amyris
Amyris (Nasdaq: AMRS) is a science
and technology leader in the research, development and production
of sustainable ingredients for the Clean Health & Beauty and
Flavors & Fragrances markets. Amyris uses an impressive array
of exclusive technologies, including state-of-the-art machine
learning, robotics and artificial intelligence. Our ingredients are
included in over 3,000 products from the world's top brands,
reaching more than 200 million consumers. Amyris is proud to own
three consumer brands - all built around its No Compromise® promise
of clean ingredients: Biossanceâ clean beauty skincare,
Pipetteâ clean baby skincare and Purecane™, a zero-calorie
sweetener naturally derived from sugarcane. For more information,
please visit www.amyris.com.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and
Purecane are trademarks or registered trademarks of Amyris, Inc. in
the U.S. and/or other countries.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amyris-hosts-successful-second-session-of-its-virtual-investor-mini-series-301225736.html
SOURCE Amyris, Inc.